查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2008462

2,5-弗蘭齊爾羧酸市場：依生產流程、純度、應用與銷售管道分類－2026-2032年全球市場預測

2,5-Furandicarboxylic Acid Market by Production Process, Purity, Application, Sales Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 195 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2,5-番木鱉羧酸市場在 2025 年的價值為 4.5188 億美元，預計到 2026 年將成長至 4.7902 億美元，複合年成長率為 5.54%，到 2032 年將達到 6.5924 億美元。

主要市場統計數據
基準年 2025 4.5188億美元
預計年份：2026年 4.7902億美元
預測年份 2032 6.5924億美元
複合年成長率 (%) 5.54%

我們將 2,5-弗蘭揚羧酸定位為核心生物基平台分子，它將重塑全球聚合物、塗料和特種化學品策略。

永續化學品領域正經歷重大變革，其驅動力包括原料經濟情勢的變化、生物基替代品監管壓力的增加以及催化和電化學途徑的創新。 2,5-弗蘭齊甲酸作為一種平台分子，在這些趨勢的交匯點上脫穎而出，在聚合物、塗料和特種化學品領域具有廣泛的應用前景。本文將該分子置於當代工業發展趨勢的背景下進行分析，並概述了影響其未來發展的因素。

技術突破、監管獎勵和策略夥伴關係的整合正在加速呋喃基化學品的工業應用和商業化。

創新、監管力道和供應鏈壓力共同作用，正在改變呋喃基化學領域的競爭格局。上游工程轉化技術的快速發展正在改變成本和碳排放結構，而催化劑系統和反應器設計的同步努力則在提高選擇性和降低能耗。除了這些技術變革之外，企業在採購過程中也越來越重視生命週期評估和認證框架，以確保生物基產品的可靠性。

2025 年貿易政策的轉變促使對採購和投資進行結構性重新評估，優先考慮整個價值鏈的韌性、本地化和供應商多元化。

近期關稅政策的發展，包括2025年實施的關稅政策，正對涉及生物基單體生產和分銷的全球供應鏈產生累積影響。原料、催化劑組分和某些半成品的關稅正在滲透到籌資策略中，促使生產商重新評估其採購區域和製造地。這些貿易措施也導致企業重新評估庫存政策和合約框架，以應對成本波動，同時履行對客戶的承諾。

透過對生產路線、純度等級、應用和分銷管道的詳細細分分析，揭示了實現商業化和價值創造的多種途徑。

為了理解市場區隔的動態變化，必須詳細檢視生產平台、純度要求、最終用途和銷售管道，因為每個維度都會影響技術和商業性策略。生質能轉化、催化氧化和電化學製程等生產路線在原料柔軟性、能源強度以及與上游生質能供應商的整合方案等方面各有優劣。生質能轉化路線往往與一體化生物煉製模式相契合，催化氧化與現有的化學工程方法相容，而電化學製程則因其模組化和易於電氣化部署的特點而備受關注。

受原料取得、監管環境和下游需求等因素影響，區域差異正在世界各地形成獨特的策略重點。

區域趨勢以不同的方式影響供需雙方，對投資者、開發商和終端用戶都具有戰略意義。在北美和拉丁美洲，成熟的化學製造群和豐富的生質能資源為早期商業計劃和中試規模部署提供了支持。同時，北美和拉丁美洲的採購團隊在選擇供應商時優先考慮本地韌性和運輸成本。該地區的政策獎勵和企業永續發展措施也有助於證明對示範規模資產和供應夥伴關係的投資是合理的。

競爭優勢將取決於技術穩健性、可靠的產品品質、可追溯的原料供應夥伴關係以及面向要求苛刻的終端市場的可擴展商業管道。

競爭格局由技術開發公司、傳統化學品製造商、特殊​​化學品製造商和垂直整合的原料供應商組成。技術開發公司專注於製程整合、延長催化劑壽命和提高提純效率，以降低操作複雜性並提高可靠性。傳統製造商正在評估設備維修和協同加工的機會，以充分利用現有資產、減少資本投資並縮短產品上市時間。特種化學品公司則專注於特定應用配方，其中呋喃單體能夠帶來性能和永續性方面的差異化優勢。

優先考慮技術選擇、品質認證、策略夥伴關係和貿易趨勢的供應策略，以加速商業化並降低部署風險。

領導者應優先考慮一系列合作舉措，以加速商業化進程並管控整個價值鏈的風險。首先，投資於部署策略，在生質能轉化、催化氧化和電化學途徑之間保持多種選擇，使生產商能夠靈活應對原料經濟和能源投入的變化。其次，建立嚴格的品質保證和認證通訊協定，涵蓋純度低於98%和高於98%的兩種水平，確保產品適用於從塗料到高性能聚合物生產等目標應用。

本報告提出的實用見解以嚴謹的混合方法為基礎，結合了相關人員訪談、技術路徑評估和供應鏈映射。

本研究整合了與關鍵相關人員的對話、技術流程分析和供應鏈映射，以深入了解技術選擇和商業性趨勢。主要資訊來源包括對製程開發人員、聚合物複合工程師、採購經理和監管專家的訪談，以支援技術假設並了解實用化的具體時間表。這些定性觀點輔以對專利文獻、關於催化和電化學方法的同行評審研究以及說明相關轉化技術材料和能量平衡的工程文獻的詳細二次分析。

要實現生物基呋喃單體的商業性潛力，必須制定整合策略協調技術選擇、品管、通路策略和區域規劃的綜合策略。

這項研究表明，2,5-番荔枝酸正處於一個關鍵的轉折點，技術成熟度、監管獎勵和採購優先事項的轉變在此交匯，共同塑造其商業化的具體路徑。儘管仍存在一些技術挑戰，特別是催化劑的耐久性、高效提純以滿足98%以上的純度要求以及如何經濟有效地整合到生質能供應鏈中，但模組化部署、供應商夥伴關係和積極的品質保證等戰略應對措施可以顯著縮短產品上市時間。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席體驗長觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章：2,5-法蘭羧酸市場：依生產流程分類

  • 生質能轉化
  • 催化氧化
  • 電化學過程

第9章：2,5-法蘭羧酸市場：依純度分類

  • 低於98%
  • 超過98%

第10章：2,5-法蘭羧酸市場：依應用分類

  • 黏合劑和密封劑
  • 塗層
  • 包裝
  • 製藥
  • 聚合物製造

第11章：2,5-法蘭羧酸市場：依銷售管道分類

  • 線下零售
  • 線上零售

第12章 2,5-法蘭羧酸市場：依地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第13章：2,5-法蘭羧酸市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章 2,5-法蘭羧酸市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章：美國：2,5-法蘭羧酸市場

第16章 中國：2,5-法蘭羧酸市場

第17章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • AstaTech Inc.
  • AVA Biochem AG
  • Avantium NV
  • BASF SE
  • Biosynth Ltd
  • Carbone Scientific CO.,LTD
  • Chemsky（shanghai）International Co., Ltd.
  • Corbion NV
  • Eastman Chemical Company
  • Merck KGaA
  • MOLBASE
  • Novamont SpA by Versalis
  • Sarchem Laboratories Inc.
  • Spectrum Laboratory Products, Inc.
  • Thermo Fisher Scientific Inc.
  • Tokyo Chemical Industry Co., Ltd
  • VIVAN Life Sciences Pvt. Limited
Product Code: MRR-C002B1C996D4

The 2,5-Furandicarboxylic Acid Market was valued at USD 451.88 million in 2025 and is projected to grow to USD 479.02 million in 2026, with a CAGR of 5.54%, reaching USD 659.24 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 451.88 million
Estimated Year [2026] USD 479.02 million
Forecast Year [2032] USD 659.24 million
CAGR (%) 5.54%

Framing 2,5-furandicarboxylic acid as a pivotal bio-based platform molecule reshaping polymer, coating, and specialty chemical strategies globally

The sustainable chemicals landscape is undergoing a material transformation driven by evolving feedstock economics, regulatory pressure for bio-based alternatives, and innovation in catalytic and electrochemical routes. 2,5-Furandicarboxylic acid has emerged at the intersection of these trends as a platform molecule with broad applicability in polymers, coatings, and specialty chemistries. This introduction situates the molecule within contemporary industrial dynamics and outlines the forces shaping near-term development.

Across the value chain, stakeholders are recalibrating priorities from purely cost-competitive production to considerations of lifecycle emissions, circularity, and supply chain resilience. As a result, technical developments in biomass conversion processes, improvements in catalytic oxidation selectivity, and the emergence of electrochemical approaches are shifting investor and developer attention. Equally important are end-use requirements for high-purity feedstocks in polymer production and pharmaceutical intermediates, which amplify the significance of process selection and downstream purification strategies.

This opening overview sets the stage for deeper analysis by framing 2,5-furandicarboxylic acid as both a technical challenge and a strategic opportunity. It emphasizes the necessity for integrated decision-making that combines process innovation, regulatory navigation, and commercial pathway development to accelerate adoption across multiple industries.

Converging technological breakthroughs, regulatory incentives, and strategic alliances are accelerating industrial adoption and commercial pathways for furanic chemistry

Innovation, regulatory momentum, and supply chain pressures are converging to transform the competitive landscape for furanic chemistries. Rapid advancements in upstream conversion technologies are altering cost and carbon profiles, while parallel work on catalyst systems and reactor design is improving selectivity and reducing energy intensity. These technological shifts are complemented by greater emphasis on lifecycle assessments and certification frameworks that validate bio-based credentials for corporate procurement.

Concurrently, strategic alliances between feedstock suppliers, catalyst developers, and polymer manufacturers are emerging to de-risk scale-up and compress commercialization timelines. Investors and strategic buyers are seeking vertically integrated solutions that combine feedstock assurance with optimized process technology. This reconfiguration is prompting legacy chemical producers to re-evaluate asset portfolios and to consider collaborations that accelerate entry into furanic value chains.

In markets where regulatory signals favor reduced embodied carbon, buyers are beginning to prioritise product portfolios that include bio-derived monomers. As a result, earlier adopters in packaging and specialty coatings are creating demand signals that influence upstream investment. Taken together, these transformative shifts are moving 2,5-furandicarboxylic acid from laboratory promise toward industrial relevance, while creating new commercial dynamics that will determine winners and fast followers in the near term.

Trade policy shifts in 2025 have driven structural sourcing and investment recalibrations that prioritize resilience, regionalisation, and supplier diversification across the value chain

Recent tariff policy developments introduced in 2025 have had a cumulative effect on global supply chains that intersect with the production and distribution of bio-based monomers. Tariffs on feedstocks, catalyst components, and certain intermediate goods have propagated through procurement strategies, prompting producers to re-evaluate sourcing geographies and manufacturing footprints. These trade measures have also led to a reassessment of inventory policies and contractual frameworks to absorb cost volatility while maintaining customer commitments.

Producers who rely on imported catalysts or specialty reagents have responded by qualifying alternate suppliers, reshoring select operations, or negotiating longer-term supply agreements with fixed pricing mechanisms. In parallel, companies with regional production capabilities have leveraged tariff differentials to optimize regional supply to local customers, thereby reducing exposure to cross-border tariff risk. These adjustments have implications for capital allocation, as some developers prioritize modular, geographically flexible assets that can shift supply to lower-tariff jurisdictions.

From a commercial perspective, downstream customers have accelerated qualification of multiple suppliers to maintain continuity in the face of potential trade disruptions. Purchasing teams are increasingly incorporating trade scenario planning into sourcing decisions, testing outcomes under different tariff regimes and logistical constraints. Consequently, the cumulative impact of tariff actions has been to catalyze structural changes in sourcing, inventory management, and investment prioritization, with an emphasis on resilience and agility across the value chain.

Granular segmentation analysis across production routes, purity tiers, applications, and distribution channels reveals differentiated routes to commercialisation and value capture

Understanding segmentation dynamics requires a close look at production platforms, purity requirements, end-use applications, and sales channels, since each dimension informs technical and commercial strategy. Production pathways such as Biomass Conversion, Catalytic Oxidation, and Electrochemical Processes present distinct trade-offs in terms of feedstock flexibility, energy intensity, and integration options with upstream biomass suppliers. Biomass conversion routes tend to align with integrated biorefinery models, catalytic oxidation offers compatibility with established chemical engineering approaches, and electrochemical processes are attracting interest for modular, electrification-aligned deployments.

Purity thresholds play a critical role in downstream suitability: materials characterised as Less than 98% often meet the needs of certain industrial coatings and adhesives, whereas grades More than 98% are required for high-performance polymer synthesis and pharmaceutical intermediates where impurity profiles can affect polymerization kinetics or regulatory compliance. Application demand profiles vary accordingly, with Adhesives & Sealants and Coatings frequently balancing cost and performance, Packaging increasingly seeking barrier and sustainability attributes linked to polymer production feedstocks, Pharmaceuticals demanding rigorous traceability and purity, and Polymer Production setting the technical bar for monomer quality and supply consistency.

Sales channels also influence commercialization tactics, as Offline Retail and Online Retail routes differ in procurement cadence, packaging formats, and customer support needs. Industrial customers sourcing through traditional offline distributors may prioritise bulk logistics and long-term contracts, while online channels enable smaller-volume orders, expedited delivery, and tighter integration with digital procurement systems. Taken together, these segmentation perspectives reveal that strategic choices in process technology, quality control, application targeting, and channel strategy must be coordinated to unlock commercial advantage.

A regionally differentiated landscape shaped by feedstock access, regulatory frameworks, and downstream demand is driving distinct strategic priorities across the globe

Regional dynamics are shaping both supply and demand in distinct ways, with strategic implications for investors, developers, and end users. In the Americas, established chemical manufacturing clusters and access to diverse biomass streams are supporting early commercial projects and pilot-scale deployments, while procurement teams in North and Latin America weigh regional resilience and transport cost in supplier selection. Policy incentives and corporate sustainability commitments in the region are also helping to justify investments in demonstration-scale assets and supply partnerships.

Europe, Middle East & Africa presents a mosaic of regulatory drivers and market maturity. Europe's circularity-focused regulations and extended producer responsibility schemes are encouraging adoption in packaging and specialty applications, whereas manufacturing hubs across the region are emphasising integration with renewable energy and waste valorisation. Middle Eastern producers are looking at feedstock export opportunities and potential for co-located, low-carbon hydrogen to support advanced production pathways, while select African markets offer feedstock potential that can be developed through partnership models and capacity-building initiatives.

Asia-Pacific remains a critical demand and manufacturing arena, driven by large polymer markets, dense downstream ecosystems, and aggressive industrial strategies to secure sustainable feedstocks. Local manufacturers are evaluating integration with petrochemical platforms as well as dedicated bio-based value chains, and regional trade patterns are influencing where capacity is sited. Across all regions, differences in regulatory frameworks, feedstock availability, and logistics shape strategic decisions regarding project scale, off-take structures, and partnership approaches.

Competitive positioning will be determined by technical robustness, validated product quality, traceable feedstock alliances, and scalable commercial routes to demanding end markets

Competitive dynamics are defined by a mix of technology developers, legacy chemical producers, specialty chemical firms, and vertically integrated feedstock suppliers. Technology developers are focusing on process intensification, catalyst lifetime, and purification efficiencies to reduce operational complexity and enhance reliability. Legacy producers are evaluating retrofit and co-processing opportunities to leverage existing assets, reduce capital outlay, and accelerate time to market. Specialty chemical firms are concentrating on application-specific formulations where furanic monomers can deliver performance or sustainability differentiation.

Partnerships between feedstock suppliers and process developers are increasingly visible as stakeholders seek to align biomass supply chains with conversion assets. This alignment reduces feedstock risk and supports traceability, which is particularly important for procurement teams that require sustainability documentation. At the same time, strategic investors are evaluating licensing pathways and toll-manufacturing arrangements to scale promising technologies without assuming full project development risk.

Competitive positioning will hinge on the ability to demonstrate cost-competitive production, validated product quality for demanding applications, and secure supply chains that withstand trade and logistics volatility. Organizations that can couple technical robustness with credible sustainability credentials and clear commercial pathways to end users will be best placed to capture early commercial opportunities.

Prioritise technology optionality, quality certification, strategic partnerships, and trade-aware supply strategies to accelerate commercialization and reduce deployment risk

Leaders should prioritise a set of coordinated actions to accelerate commercialization and manage risk across the value chain. First, invest in deployment strategies that preserve optionality between biomass conversion, catalytic oxidation, and electrochemical routes, allowing producers to pivot as feedstock economics and energy inputs evolve. Second, establish rigorous quality assurance and certification protocols that address both Less than 98% and More than 98% purity tiers, ensuring compatibility with targeted applications from coatings to high-performance polymer production.

Third, pursue strategic partnerships that link feedstock suppliers, catalyst developers, and downstream customers to align incentives and shorten qualification cycles. Fourth, integrate trade scenario planning into capital allocation and procurement policies to mitigate tariff and logistical risks through regional capacity planning and supplier diversification. Finally, accelerate application development efforts in Adhesives & Sealants, Coatings, Packaging, Pharmaceuticals, and Polymer Production by co-developing formulations and qualification programs with key customers, while using both Offline Retail and Online Retail channels to tailor distribution approaches for different volumes and service expectations.

Taken together, these actions will enhance agility, reduce commercialization friction, and create clearer pathways to capture value as markets for bio-derived monomers mature.

A rigorous mixed-methods approach combining stakeholder interviews, technical pathway assessment, and supply chain mapping underpins the actionable insights presented

This research integrates primary stakeholder engagement, technical process analysis, and supply chain mapping to develop robust insights into technology choices and commercial dynamics. Primary inputs include interviews with process developers, polymer formulators, procurement leaders, and regulatory experts to ground technical assumptions and capture practical qualification timelines. These qualitative perspectives are supplemented by detailed secondary analysis of patent literature, peer-reviewed studies on catalytic and electrochemical methods, and engineering literature that describes mass and energy balances for relevant conversion technologies.

Analytical methods include comparative pathway assessment across biomass conversion, catalytic oxidation, and electrochemical routes, with attention to feedstock inputs, impurity profiles, and purification requirements linked to purity tiers. Scenario-based trade impact modeling examines procurement strategies and regional capacity options to understand how tariff measures affect sourcing and investment decisions. Supply chain mapping highlights critical nodes for catalysts, specialty reagents, and purification equipment, and informs risk mitigation recommendations.

Throughout, findings were validated through iterative expert review cycles to ensure technical accuracy and practical relevance. The methodology aims to balance depth of technical assessment with actionable commercial intelligence to support decision-makers across development, procurement, and strategy functions.

An integrated strategy aligning technology selection, quality control, channel strategy, and regional planning is essential to realise the commercial potential of bio-derived furanic monomers

The synthesis reveals that 2,5-furandicarboxylic acid stands at a pivotal inflection point where technological maturity, regulatory incentives, and shifting procurement priorities converge to create tangible pathways for commercialization. While technical challenges remain-particularly around catalyst durability, efficient purification to meet More than 98% specifications, and cost-effective integration with biomass supply chains-strategic responses such as modular deployment, supplier partnerships, and proactive quality assurance can materially reduce time to market.

Moreover, trade policy developments underscore the need for flexible sourcing strategies and regionalized capacity planning to preserve competitiveness and continuity of supply. Application-led demand from coatings, packaging, adhesives, pharmaceuticals, and polymer production will continue to shape investment priorities, with early adopters in performance-sensitive segments likely to drive initial commercial traction. Ultimately, organizations that align process selection, quality strategy, and go-to-market channels with regional considerations will be positioned to convert scientific promise into reliable commercial outcomes.

This conclusion reinforces the importance of an integrated approach that blends technical excellence with commercial pragmatism and regulatory foresight to unlock the full potential of bio-based furanic monomers.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. 2,5-Furandicarboxylic Acid Market, by Production Process

  • 8.1. Biomass Conversion
  • 8.2. Catalytic Oxidation
  • 8.3. Electrochemical Processes

9. 2,5-Furandicarboxylic Acid Market, by Purity

  • 9.1. Less than 98%
  • 9.2. More than 98%

10. 2,5-Furandicarboxylic Acid Market, by Application

  • 10.1. Adhesives & Sealants
  • 10.2. Coatings
  • 10.3. Packaging
  • 10.4. Pharmaceuticals
  • 10.5. Polymer Production

11. 2,5-Furandicarboxylic Acid Market, by Sales Channel

  • 11.1. Offline Retail
  • 11.2. Online Retail

12. 2,5-Furandicarboxylic Acid Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. 2,5-Furandicarboxylic Acid Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. 2,5-Furandicarboxylic Acid Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States 2,5-Furandicarboxylic Acid Market

16. China 2,5-Furandicarboxylic Acid Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. AstaTech Inc.
  • 17.6. AVA Biochem AG
  • 17.7. Avantium N.V.
  • 17.8. BASF SE
  • 17.9. Biosynth Ltd
  • 17.10. Carbone Scientific CO.,LTD
  • 17.11. Chemsky (shanghai) International Co., Ltd.
  • 17.12. Corbion NV
  • 17.13. Eastman Chemical Company
  • 17.14. Merck KGaA
  • 17.15. MOLBASE
  • 17.16. Novamont S.p.A. by Versalis
  • 17.17. Sarchem Laboratories Inc.
  • 17.18. Spectrum Laboratory Products, Inc.
  • 17.19. Thermo Fisher Scientific Inc.
  • 17.20. Tokyo Chemical Industry Co., Ltd
  • 17.21. VIVAN Life Sciences Pvt. Limited

LIST OF FIGURES

  • FIGURE 1. GLOBAL 2,5-FURANDICARBOXYLIC ACID MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL 2,5-FURANDICARBOXYLIC ACID MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL 2,5-FURANDICARBOXYLIC ACID MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL 2,5-FURANDICARBOXYLIC ACID MARKET SIZE, BY PRODUCTION PROCESS, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL 2,5-FURANDICARBOXYLIC ACID MARKET SIZE, BY PURITY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL 2,5-FURANDICARBOXYLIC ACID MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL 2,5-FURANDICARBOXYLIC ACID MARKET SIZE, BY SALES CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL 2,5-FURANDICARBOXYLIC ACID MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL 2,5-FURANDICARBOXYLIC ACID MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL 2,5-FURANDICARBOXYLIC ACID MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES 2,5-FURANDICARBOXYLIC ACID MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA 2,5-FURANDICARBOXYLIC ACID MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL 2,5-FURANDICARBOXYLIC ACID MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL 2,5-FURANDICARBOXYLIC ACID MARKET SIZE, BY PRODUCTION PROCESS, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL 2,5-FURANDICARBOXYLIC ACID MARKET SIZE, BY BIOMASS CONVERSION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL 2,5-FURANDICARBOXYLIC ACID MARKET SIZE, BY BIOMASS CONVERSION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL 2,5-FURANDICARBOXYLIC ACID MARKET SIZE, BY BIOMASS CONVERSION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL 2,5-FURANDICARBOXYLIC ACID MARKET SIZE, BY CATALYTIC OXIDATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL 2,5-FURANDICARBOXYLIC ACID MARKET SIZE, BY CATALYTIC OXIDATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL 2,5-FURANDICARBOXYLIC ACID MARKET SIZE, BY CATALYTIC OXIDATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL 2,5-FURANDICARBOXYLIC ACID MARKET SIZE, BY ELECTROCHEMICAL PROCESSES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL 2,5-FURANDICARBOXYLIC ACID MARKET SIZE, BY ELECTROCHEMICAL PROCESSES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL 2,5-FURANDICARBOXYLIC ACID MARKET SIZE, BY ELECTROCHEMICAL PROCESSES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL 2,5-FURANDICARBOXYLIC ACID MARKET SIZE, BY PURITY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL 2,5-FURANDICARBOXYLIC ACID MARKET SIZE, BY LESS THAN 98%, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL 2,5-FURANDICARBOXYLIC ACID MARKET SIZE, BY LESS THAN 98%, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL 2,5-FURANDICARBOXYLIC ACID MARKET SIZE, BY LESS THAN 98%, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL 2,5-FURANDICARBOXYLIC ACID MARKET SIZE, BY MORE THAN 98%, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL 2,5-FURANDICARBOXYLIC ACID MARKET SIZE, BY MORE THAN 98%, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL 2,5-FURANDICARBOXYLIC ACID MARKET SIZE, BY MORE THAN 98%, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL 2,5-FURANDICARBOXYLIC ACID MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL 2,5-FURANDICARBOXYLIC ACID MARKET SIZE, BY ADHESIVES & SEALANTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL 2,5-FURANDICARBOXYLIC ACID MARKET SIZE, BY ADHESIVES & SEALANTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL 2,5-FURANDICARBOXYLIC ACID MARKET SIZE, BY ADHESIVES & SEALANTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL 2,5-FURANDICARBOXYLIC ACID MARKET SIZE, BY COATINGS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL 2,5-FURANDICARBOXYLIC ACID MARKET SIZE, BY COATINGS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL 2,5-FURANDICARBOXYLIC ACID MARKET SIZE, BY COATINGS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL 2,5-FURANDICARBOXYLIC ACID MARKET SIZE, BY PACKAGING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL 2,5-FURANDICARBOXYLIC ACID MARKET SIZE, BY PACKAGING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL 2,5-FURANDICARBOXYLIC ACID MARKET SIZE, BY PACKAGING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL 2,5-FURANDICARBOXYLIC ACID MARKET SIZE, BY PHARMACEUTICALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL 2,5-FURANDICARBOXYLIC ACID MARKET SIZE, BY PHARMACEUTICALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL 2,5-FURANDICARBOXYLIC ACID MARKET SIZE, BY PHARMACEUTICALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL 2,5-FURANDICARBOXYLIC ACID MARKET SIZE, BY POLYMER PRODUCTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL 2,5-FURANDICARBOXYLIC ACID MARKET SIZE, BY POLYMER PRODUCTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL 2,5-FURANDICARBOXYLIC ACID MARKET SIZE, BY POLYMER PRODUCTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL 2,5-FURANDICARBOXYLIC ACID MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL 2,5-FURANDICARBOXYLIC ACID MARKET SIZE, BY OFFLINE RETAIL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL 2,5-FURANDICARBOXYLIC ACID MARKET SIZE, BY OFFLINE RETAIL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL 2,5-FURANDICARBOXYLIC ACID MARKET SIZE, BY OFFLINE RETAIL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL 2,5-FURANDICARBOXYLIC ACID MARKET SIZE, BY ONLINE RETAIL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL 2,5-FURANDICARBOXYLIC ACID MARKET SIZE, BY ONLINE RETAIL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL 2,5-FURANDICARBOXYLIC ACID MARKET SIZE, BY ONLINE RETAIL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL 2,5-FURANDICARBOXYLIC ACID MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. AMERICAS 2,5-FURANDICARBOXYLIC ACID MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 44. AMERICAS 2,5-FURANDICARBOXYLIC ACID MARKET SIZE, BY PRODUCTION PROCESS, 2018-2032 (USD MILLION)
  • TABLE 45. AMERICAS 2,5-FURANDICARBOXYLIC ACID MARKET SIZE, BY PURITY, 2018-2032 (USD MILLION)
  • TABLE 46. AMERICAS 2,5-FURANDICARBOXYLIC ACID MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 47. AMERICAS 2,5-FURANDICARBOXYLIC ACID MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 48. NORTH AMERICA 2,5-FURANDICARBOXYLIC ACID MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. NORTH AMERICA 2,5-FURANDICARBOXYLIC ACID MARKET SIZE, BY PRODUCTION PROCESS, 2018-2032 (USD MILLION)
  • TABLE 50. NORTH AMERICA 2,5-FURANDICARBOXYLIC ACID MARKET SIZE, BY PURITY, 2018-2032 (USD MILLION)
  • TABLE 51. NORTH AMERICA 2,5-FURANDICARBOXYLIC ACID MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 52. NORTH AMERICA 2,5-FURANDICARBOXYLIC ACID MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 53. LATIN AMERICA 2,5-FURANDICARBOXYLIC ACID MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. LATIN AMERICA 2,5-FURANDICARBOXYLIC ACID MARKET SIZE, BY PRODUCTION PROCESS, 2018-2032 (USD MILLION)
  • TABLE 55. LATIN AMERICA 2,5-FURANDICARBOXYLIC ACID MARKET SIZE, BY PURITY, 2018-2032 (USD MILLION)
  • TABLE 56. LATIN AMERICA 2,5-FURANDICARBOXYLIC ACID MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 57. LATIN AMERICA 2,5-FURANDICARBOXYLIC ACID MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 58. EUROPE, MIDDLE EAST & AFRICA 2,5-FURANDICARBOXYLIC ACID MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 59. EUROPE, MIDDLE EAST & AFRICA 2,5-FURANDICARBOXYLIC ACID MARKET SIZE, BY PRODUCTION PROCESS, 2018-2032 (USD MILLION)
  • TABLE 60. EUROPE, MIDDLE EAST & AFRICA 2,5-FURANDICARBOXYLIC ACID MARKET SIZE, BY PURITY, 2018-2032 (USD MILLION)
  • TABLE 61. EUROPE, MIDDLE EAST & AFRICA 2,5-FURANDICARBOXYLIC ACID MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 62. EUROPE, MIDDLE EAST & AFRICA 2,5-FURANDICARBOXYLIC ACID MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 63. EUROPE 2,5-FURANDICARBOXYLIC ACID MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. EUROPE 2,5-FURANDICARBOXYLIC ACID MARKET SIZE, BY PRODUCTION PROCESS, 2018-2032 (USD MILLION)
  • TABLE 65. EUROPE 2,5-FURANDICARBOXYLIC ACID MARKET SIZE, BY PURITY, 2018-2032 (USD MILLION)
  • TABLE 66. EUROPE 2,5-FURANDICARBOXYLIC ACID MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 67. EUROPE 2,5-FURANDICARBOXYLIC ACID MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 68. MIDDLE EAST 2,5-FURANDICARBOXYLIC ACID MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. MIDDLE EAST 2,5-FURANDICARBOXYLIC ACID MARKET SIZE, BY PRODUCTION PROCESS, 2018-2032 (USD MILLION)
  • TABLE 70. MIDDLE EAST 2,5-FURANDICARBOXYLIC ACID MARKET SIZE, BY PURITY, 2018-2032 (USD MILLION)
  • TABLE 71. MIDDLE EAST 2,5-FURANDICARBOXYLIC ACID MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 72. MIDDLE EAST 2,5-FURANDICARBOXYLIC ACID MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 73. AFRICA 2,5-FURANDICARBOXYLIC ACID MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 74. AFRICA 2,5-FURANDICARBOXYLIC ACID MARKET SIZE, BY PRODUCTION PROCESS, 2018-2032 (USD MILLION)
  • TABLE 75. AFRICA 2,5-FURANDICARBOXYLIC ACID MARKET SIZE, BY PURITY, 2018-2032 (USD MILLION)
  • TABLE 76. AFRICA 2,5-FURANDICARBOXYLIC ACID MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 77. AFRICA 2,5-FURANDICARBOXYLIC ACID MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 78. ASIA-PACIFIC 2,5-FURANDICARBOXYLIC ACID MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 79. ASIA-PACIFIC 2,5-FURANDICARBOXYLIC ACID MARKET SIZE, BY PRODUCTION PROCESS, 2018-2032 (USD MILLION)
  • TABLE 80. ASIA-PACIFIC 2,5-FURANDICARBOXYLIC ACID MARKET SIZE, BY PURITY, 2018-2032 (USD MILLION)
  • TABLE 81. ASIA-PACIFIC 2,5-FURANDICARBOXYLIC ACID MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 82. ASIA-PACIFIC 2,5-FURANDICARBOXYLIC ACID MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL 2,5-FURANDICARBOXYLIC ACID MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 84. ASEAN 2,5-FURANDICARBOXYLIC ACID MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 85. ASEAN 2,5-FURANDICARBOXYLIC ACID MARKET SIZE, BY PRODUCTION PROCESS, 2018-2032 (USD MILLION)
  • TABLE 86. ASEAN 2,5-FURANDICARBOXYLIC ACID MARKET SIZE, BY PURITY, 2018-2032 (USD MILLION)
  • TABLE 87. ASEAN 2,5-FURANDICARBOXYLIC ACID MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 88. ASEAN 2,5-FURANDICARBOXYLIC ACID MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 89. GCC 2,5-FURANDICARBOXYLIC ACID MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. GCC 2,5-FURANDICARBOXYLIC ACID MARKET SIZE, BY PRODUCTION PROCESS, 2018-2032 (USD MILLION)
  • TABLE 91. GCC 2,5-FURANDICARBOXYLIC ACID MARKET SIZE, BY PURITY, 2018-2032 (USD MILLION)
  • TABLE 92. GCC 2,5-FURANDICARBOXYLIC ACID MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 93. GCC 2,5-FURANDICARBOXYLIC ACID MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 94. EUROPEAN UNION 2,5-FURANDICARBOXYLIC ACID MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 95. EUROPEAN UNION 2,5-FURANDICARBOXYLIC ACID MARKET SIZE, BY PRODUCTION PROCESS, 2018-2032 (USD MILLION)
  • TABLE 96. EUROPEAN UNION 2,5-FURANDICARBOXYLIC ACID MARKET SIZE, BY PURITY, 2018-2032 (USD MILLION)
  • TABLE 97. EUROPEAN UNION 2,5-FURANDICARBOXYLIC ACID MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 98. EUROPEAN UNION 2,5-FURANDICARBOXYLIC ACID MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 99. BRICS 2,5-FURANDICARBOXYLIC ACID MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 100. BRICS 2,5-FURANDICARBOXYLIC ACID MARKET SIZE, BY PRODUCTION PROCESS, 2018-2032 (USD MILLION)
  • TABLE 101. BRICS 2,5-FURANDICARBOXYLIC ACID MARKET SIZE, BY PURITY, 2018-2032 (USD MILLION)
  • TABLE 102. BRICS 2,5-FURANDICARBOXYLIC ACID MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 103. BRICS 2,5-FURANDICARBOXYLIC ACID MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 104. G7 2,5-FURANDICARBOXYLIC ACID MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 105. G7 2,5-FURANDICARBOXYLIC ACID MARKET SIZE, BY PRODUCTION PROCESS, 2018-2032 (USD MILLION)
  • TABLE 106. G7 2,5-FURANDICARBOXYLIC ACID MARKET SIZE, BY PURITY, 2018-2032 (USD MILLION)
  • TABLE 107. G7 2,5-FURANDICARBOXYLIC ACID MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 108. G7 2,5-FURANDICARBOXYLIC ACID MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 109. NATO 2,5-FURANDICARBOXYLIC ACID MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 110. NATO 2,5-FURANDICARBOXYLIC ACID MARKET SIZE, BY PRODUCTION PROCESS, 2018-2032 (USD MILLION)
  • TABLE 111. NATO 2,5-FURANDICARBOXYLIC ACID MARKET SIZE, BY PURITY, 2018-2032 (USD MILLION)
  • TABLE 112. NATO 2,5-FURANDICARBOXYLIC ACID MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 113. NATO 2,5-FURANDICARBOXYLIC ACID MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL 2,5-FURANDICARBOXYLIC ACID MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 115. UNITED STATES 2,5-FURANDICARBOXYLIC ACID MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 116. UNITED STATES 2,5-FURANDICARBOXYLIC ACID MARKET SIZE, BY PRODUCTION PROCESS, 2018-2032 (USD MILLION)
  • TABLE 117. UNITED STATES 2,5-FURANDICARBOXYLIC ACID MARKET SIZE, BY PURITY, 2018-2032 (USD MILLION)
  • TABLE 118. UNITED STATES 2,5-FURANDICARBOXYLIC ACID MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 119. UNITED STATES 2,5-FURANDICARBOXYLIC ACID MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 120. CHINA 2,5-FURANDICARBOXYLIC ACID MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 121. CHINA 2,5-FURANDICARBOXYLIC ACID MARKET SIZE, BY PRODUCTION PROCESS, 2018-2032 (USD MILLION)
  • TABLE 122. CHINA 2,5-FURANDICARBOXYLIC ACID MARKET SIZE, BY PURITY, 2018-2032 (USD MILLION)
  • TABLE 123. CHINA 2,5-FURANDICARBOXYLIC ACID MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 124. CHINA 2,5-FURANDICARBOXYLIC ACID MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)